US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
00

002727.SZ

$10.89
Sharia status
NOT COMPLIANT
Per In-house ratio engine · assessed 2026-08-26
HTR non-permissible income 0.12%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Yixintang Pharmaceutical Group Co., Ltd. (002727.SZ) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-26). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

Market & analysts
Price target
$13.19
+21.1% · 5 analysts
Institutional own.
8.0%
of shares
NON-COMPLIANT
Sharia compliance
0.12%
Non-permissible income — HTR, from filings (2025-12-31)
$13.19
Price target (+21.1%) · 5 analysts
8.0%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. 002727.SZ files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail

RatioValueThresholdResult
Interest-bearing debt 54.04% 30.00% Fail
Interest-bearing investments 42.39% 30.00% Fail
Non-permissible income 0.12% 5.00% Pass

Usmani Pass

RatioValueThresholdResult
Interest-bearing debt 25.01% 33.00% Pass
Interest-bearing investments 19.62% 33.00% Pass
Non-liquid assets 71.65% at least 20.00% Pass
Non-permissible income 0.12% 5.00% Pass

MSCI Pass

RatioValueThresholdResult
Interest-bearing debt 25.01% 33.33% Pass
Cash + interest-bearing securities 19.62% 33.33% Pass
Accounts receivable 28.35% 33.33% Pass
Non-permissible income 0.12% 5.00% Pass

FTSE Pass

RatioValueThresholdResult
Interest-bearing debt 25.01% 33.33% Pass
Cash + interest-bearing securities 19.62% 33.33% Pass
Accounts receivable 28.35% 50.00% Pass
Non-permissible income 0.12% 5.00% Pass

Dow Jones Islamic Market Fail

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 46.05% 33.00% Fail
Cash + interest-bearing securities 36.13% 33.00% Fail
Accounts receivable 16.07% 33.00% Pass
Non-permissible income 0.12% 5.00% Pass

S&P Shariah Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 39.39% 33.00% Fail
Cash + interest-bearing securities 30.90% 49.00% Pass
Accounts receivable 13.75% 49.00% Pass
Non-permissible income 0.12% 5.00% Pass

MSCI M-Series Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 39.39% 33.33% Fail
Cash + interest-bearing securities 30.90% 33.33% Pass
Accounts receivable 44.65% 49.00% Pass
Non-permissible income 0.12% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

14.6813.4112.1310.869.592025-09-112026-03-192026-09-10

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
11.11
S2
11.17
S1
11.22
PIVOT
11.28
R1
11.33
R2
11.39
R3
11.44

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
10.4776 12.0424
±6.95% from 11.26, made 2026-09-04 · resolves 2026-09-11
STRONG SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22183 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsSELL
2 buy · 2 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)42.40NEUTRAL
Stochastic %K (14)5.81BUY
CCI (20)-98.45NEUTRAL
Williams %R (14)-94.19BUY
MACD (12,26,9)-0.05SELL
ROC (10)-2.38SELL
Momentum (10)-0.27SELL
EMA (10)11.29SELL
SMA (10)11.25SELL
EMA (20)11.39SELL
SMA (20)11.48SELL
EMA (30)11.40SELL
SMA (30)11.58SELL
EMA (50)11.40SELL
SMA (50)11.33SELL
EMA (100)11.58SELL
SMA (100)11.42SELL
EMA (200)12.28SELL
SMA (200)12.20SELL

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About Yixintang Pharmaceutical Group Co., Ltd.

Healthcare · Pharmaceutical Retailers

Yixintang Pharmaceutical Group Co., Ltd., together with its subsidiary, engages in the pharmaceutical retail chain and pharmaceutical distribution business. The company is involved in the wholesale, retail, leasing, and operation of medical devices; sale of food, disinfectants, disinfection equipment, and disposable medical products, household appliances, adult toys, agricultural and sideline products, cosmetics, and daily sundries and necessities; manufacturing of glasses; provision of value-added telecommunications, Internet live broadcast technology, and Internet information services for medicines, as well as clinic and foot bath services; operation of aquatic wild animals and call center; retail of publications; and decoction services for Chinese herbal medicines. It also engages in the agency sale of single-purpose commercial prepaid cards and China sports lottery; and maternal and child care activities. In addition, the company provides health care, housekeeping, amusement park, residents' daily life, and health consulting service, as well as business agency, ticket agency, personal Internet live broadcast, remote health management, corporate member points management, food delivery, and road freight transportation services. Further, it is involved in the import and export of goods and technology; wholesale of pet food and supplies; and wholesale of clothing and accessories. Additionally, the company sells products online. The company was formerly known as Yunnan Hongxiang Yixintang Pharmaceutical Co., Ltd. and changed its name to Yixintang Pharmaceutical Group Co., Ltd. in June 2019. Yixintang Pharmaceutical Group Co., Ltd. was founded in 2000 and is headquartered in Kunming, China.

hx8886.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-01 · Asset managers net 934180 (-19048)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.